Topics-> 4; Sub-Topics-> 6; Figures-> 14; This Database covers Norway Self-Monitoring of Blood Glucose (SMBG) market (Test Strips, Lancet, Meters) & User, Diabetes Population (Type1 & 2) Reimbursement Policies and Forecast upto 2020....
Europe multiple sclerosis market potential is of more than US$ 5 Billion by 2022. But only more than half this market is expected to be actually achieved. This huge difference between actual market and unmet market is due to gap between number of patients who require multiple sclerosis drugs and num...
Global multiple sclerosis market is steadily growing and it is expected to cross over US$ 20 Billion landmark by 2022. Multiple sclerosis market is one of the most common neurological disorder diseases in the world. Â It is estimated that global multiple sclerosis patient numbers will increase aroun...
USA insulin pump market is expected to grow more than US$ 5 Billion by the end of year 2022. The convenience of using insulin pump are gaining inclusive acceptance in the market as insulin delivery systems. Now insulin Pump has become famous and a preferred device for Type1 diabetes patients in the ...
Global Pediatric Proton Therapy Market has potential of more than US$ 700 Million by 2021. Rising pediatric cancer incidence and technological improvement to treat faster per patient will boost the pediatric proton therapy market globally. ...
As per Renub Research analysis China Cancer Test Market is projected to cross US$ 24 Billion by the end of 2022. In China, cancer cases are rising and are one of the major causes of deaths in urban and rural areas. In order to mitigate cancer prevalence in China; the government focuses on several Ca...
Europe Pediatric Proton Therapy Market has a market potential close to US$ 150 Million by 2022. The rise of pediatric cancer incidence in Europe region and proton therapy gaining prominence and credibility among radiation oncologist will motivate the investor to invest in it. As of now, the pediatri...
Cardiometabolic products and services provide timely cardiovascular and metabolic information at the point-of-care. Until today, Troponin and CK-MB were the lead cardiac markers. Brain Natriuetic Pepetide (BNP) was recently introduced to differentiate between a Myocardial Infarction and Heart Failur...
USA Pediatric Proton Therapy Market has potential to reach close to US$ 350 Million by the end of year 2021. But its actual market is predicted to be less than even half of this figure. The difference between this actual and potential market is due to its demand and supply gap. In United States, the...
Europe Proton Therapy Market has a market potential of much more than US$ 10 Billion in 2016. In the year 2009 France used be have the highest proton therapy market share. But by 2012 Germany replaced France from the top position and it continues to hold its top position in 2016 as well. According t...
Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting.